Nanomedicine, an application of nanotechnology in medical science, is an evolving market. It represents an important segment of nanotechnology which will significantly change the course of treating life threatening diseases. This, unlike other treatment options, is significantly expected to enhance efficacy and minimize overall adversities. Toxicity and environmental impact of nanoscale materials are the major problems nanomedicine. Research and development in nanomedicine is expected to offer a pool of novel products which will improve the health of patients. The robust product pipeline for nanobiomaterials poses a health picture of the market creates significant growth opportunities. However these will have to go through stringent testing protocols before commercialization.
The drug delivery market is the largest contributing application segment, whereas biomaterials is the fatetst growing application area in this market. Major market players in this market include Abraxis BioScience Inc., AMAG Pharmaceuticals Inc., Arrowhead Research Corp., Crucell N.V., Flamel Technologies S.A., Elan Corporation Plc, Enzon Pharmaceuticals Inc., Life Technologies Corp., Nanosphere Inc., Nektar Therapeutics, Novavax Inc., Oxonica Plc, Par Pharmaceutical Companies Inc., Starpharma Holdings Limited, and others.
Benchmarking the rapid strategy shifts of the Top 100 companies in the Global Nanomedical Devices and Therapeutics MarketRequest For Special Pricing